Pep2Tango Therapeutics Inc.
PrivateLast Round
VC Round
Nov 21, 2024
Company Overview
Pep2Tango Therapeutics Inc. operates in Healthcare & Life Sciences and is based in Potomac, Maryland. Its latest recorded funding round was a VC Round in November 2024.
Pep2Tango Therapeutics Inc. is a biotechnology company developing next-generation unimolecular multi-agonist peptides for obesity and associated metabolic disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Pep2Tango Therapeutics Inc. Comparables
Compare Pep2Tango Therapeutics Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Helicore Biopharma | 85% | |
| AstraZeneca | 83% | |
| Alveus Therapeutics | 82% |
For institutional investors. Book with your work email.
Pep2Tango Therapeutics Inc. Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Pep2Tango Therapeutics Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Versant Ventures | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 21, 2024
$17M round led by Versant Ventures.
For institutional investors. Book with your work email.
Pep2Tango Therapeutics Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Pep2Tango Therapeutics Inc.'s valuation, stock price, and market status.
Is Pep2Tango Therapeutics Inc. a public or private company?
Pep2Tango Therapeutics Inc. is a private company.
What is the current stock price of Pep2Tango Therapeutics Inc.?
Pep2Tango Therapeutics Inc. is a private company, so its shares have no public market price. Caplight tracks Pep2Tango Therapeutics Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Pep2Tango Therapeutics Inc. worth (valuation)?
Valuation information for Pep2Tango Therapeutics Inc. is not publicly available.
Can I buy Pep2Tango Therapeutics Inc. stock?
Pep2Tango Therapeutics Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Pep2Tango Therapeutics Inc.'s last funding round?
Pep2Tango Therapeutics Inc.'s most recent funding round was VC Round on November 21, 2024.
Who are the main investors in Pep2Tango Therapeutics Inc.?
Key investors in Pep2Tango Therapeutics Inc. include Versant Ventures.
Will Pep2Tango Therapeutics Inc. IPO soon?
No public IPO plans have been announced for Pep2Tango Therapeutics Inc..
How can I track Pep2Tango Therapeutics Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Pep2Tango Therapeutics Inc.'s shares on secondary markets.